Variant report
Variant | nsv1016480 |
---|---|
Chromosome Location | chr5:152261713-152313172 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-NMUR2-1 | chr5:152264987-152265188 | XLOC_005056 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs191571019 | chr5:152261756-152261757 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs527756200 | chr5:152261764-152261765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs544939294 | chr5:152261773-152261774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs142055312 | chr5:152261792-152261793 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs112304815 | chr5:152261863-152261864 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs80350780 | chr5:152261926-152261927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs181702129 | chr5:152261933-152261934 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs199742243 | chr5:152261952-152261953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs557328316 | chr5:152261979-152261980 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs75983152 | chr5:152261980-152261981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs376015284 | chr5:152262033-152262034 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs151132739 | chr5:152262127-152262128 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs139098873 | chr5:152262136-152262137 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs187166418 | chr5:152262142-152262143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs191806344 | chr5:152262171-152262172 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs557463678 | chr5:152262205-152262206 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs183406410 | chr5:152262222-152262223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs186661397 | chr5:152262355-152262356 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs556348740 | chr5:152262398-152262399 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs144027581 | chr5:152262408-152262409 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs542533260 | chr5:152262427-152262428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs35433876 | chr5:152262446-152262447 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs60620453 | chr5:152262480-152262481 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs80258307 | chr5:152262484-152262485 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs189935883 | chr5:152262500-152262501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs564620251 | chr5:152262502-152262503 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs146458553 | chr5:152262542-152262543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs543599256 | chr5:152262543-152262544 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs182419745 | chr5:152262571-152262572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs376623377 | chr5:152262636-152262637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs561397930 | chr5:152262670-152262671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs369941672 | chr5:152262718-152262719 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs547683991 | chr5:152262733-152262734 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs528613560 | chr5:152262751-152262752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs79460323 | chr5:152262766-152262767 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs546995895 | chr5:152262769-152262770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs140995592 | chr5:152262854-152262855 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs35729824 | chr5:152262861-152262862 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs551057877 | chr5:152262889-152262890 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs569452576 | chr5:152262898-152262899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs536752803 | chr5:152262905-152262906 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs145623796 | chr5:152262909-152262910 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs76373017 | chr5:152262942-152262943 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs148914071 | chr5:152262962-152262963 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs554478897 | chr5:152263009-152263010 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs572348078 | chr5:152263018-152263019 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs187124091 | chr5:152263039-152263040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs193003793 | chr5:152263063-152263064 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs576555765 | chr5:152263073-152263074 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs577262131 | chr5:152263086-152263087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Breast cancer | 17603634 | CNVD |
Crohn''s disease | 20106866 | CNVD |
Breast cancer | 20409316 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Deafness | 19353646 | CNVD |
Developmental delay | 19353646 | CNVD |
dysmorphism | 19353646 | CNVD |
feeding difficulties | 19353646 | CNVD |
strabismus | 19353646 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:152261400-152262800 | Enhancers | Fetal Brain Male | brain |
2 | chr5:152262000-152263200 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
3 | chr5:152262200-152264800 | Enhancers | Brain Germinal Matrix | brain |
4 | chr5:152262400-152263200 | Enhancers | Fetal Brain Female | brain |
5 | chr5:152279800-152280200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr5:152279800-152280600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
7 | chr5:152279800-152280800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
8 | chr5:152280000-152280600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
9 | chr5:152280000-152280800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
10 | chr5:152281200-152282200 | Enhancers | Liver | Liver |
11 | chr5:152282200-152287000 | Weak transcription | Liver | Liver |
12 | chr5:152287000-152287400 | Active TSS | Pancreatic Islets | Pancreatic Islet |
13 | chr5:152287000-152287600 | Active TSS | Liver | Liver |
14 | chr5:152287400-152287600 | Flanking Active TSS | Pancreatic Islets | Pancreatic Islet |
15 | chr5:152287600-152287800 | Flanking Active TSS | Liver | Liver |
16 | chr5:152287800-152288000 | Enhancers | Liver | Liver |
17 | chr5:152289600-152289800 | Enhancers | Liver | Liver |
18 | chr5:152304600-152306000 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
19 | chr5:152305600-152305800 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
20 | chr5:152306400-152306800 | Enhancers | Pancreatic Islets | Pancreatic Islet |
21 | chr5:152307600-152308000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
22 | chr5:152308000-152309400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
23 | chr5:152309400-152310000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
24 | chr5:152312400-152313000 | Enhancers | Cortex derived primary cultured neurospheres | brain |